U
Sage Potash Corp. SAGE.V
TSX
Recommendation
Prev Close
$0.30
Volume
--
Avg Vol (90D)
162,215
Market Cap
$17.94M
Dividend & Yield
--
52-Week Range
$0.13 - $0.39
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Sage Therapeutics (SAGE, $9.08) Stochastic Oscillator left the oversold zone on July 02, 2025
7/3/2025 - Tickeron - Stocks
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HONE, FL, SAGE on Behalf of Shareholders
7/1/2025 - PR Newswire
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Sage Therapeutics, Inc. (NASDAQ: SAGE)
7/1/2025 - Globe Newswire
What Makes Sage Therapeutics (SAGE) a New Buy Stock
7/1/2025 - Zacks Investment Research
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
7/1/2025 - Globe Newswire
Sage Therapeutics cutting over 330 jobs, Boston Globe reports
7/1/2025 - The Fly
sage lays entire staff 338 following its takeover supernus
6/30/2025 - FiercePharma
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, CTLP, SAGE on Behalf of Shareholders
6/27/2025 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNTY, CHTR, SAGE, TASK on Behalf of Shareholders
6/25/2025 - Globe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SAGE, SOL on Behalf of Shareholders
6/23/2025 - PR Newswire
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
6/23/2025 - Globe Newswire
Sage Therapeutics Stock: JPMorgan Sees 8% Downside After Supernus Buyout Terms
6/23/2025 - Stocktwits News Feed
Sage Therapeutics price target lowered to $8.50 from $11 at JPMorgan
6/22/2025 - TipRanks Financial Blog
Sage Therapeutics price target lowered by $2.50 at JPMorgan, here's why
6/22/2025 - The Fly
J.P. Morgan Remains a Hold on SAGE Therapeutics (SAGE)
6/22/2025 - TipRanks Financial Blog
SAGE: Baird Adjusts Price Target on Sage Therapeutics SAGE Stock News
6/20/2025 - GuruFocus
Sage Therapeutics (NASDAQ:SAGE) Price Target Raised to $9.00
6/20/2025 - Ticker Report
Sage Therapeutics (NASDAQ:SAGE) Given New $9.00 Price Target at Robert W. Baird
6/20/2025 - MarketBeat
Sage Therapeutics price target raised to $9 from $7 at Baird
6/20/2025 - TipRanks Financial Blog
Sage Therapeutics price target raised by $2 at Baird, here's why
6/20/2025 - The Fly
Sage Therapeutics (NASDAQ:SAGE) Cut to Hold at Piper Sandler
6/20/2025 - Ticker Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, COLB on Behalf of Shareholders
6/19/2025 - PR Newswire
SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & ...
6/19/2025 - GuruFocus
SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE
6/19/2025 - Business Wire
Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Average Recommendation of "Hold" by Brokerages
6/18/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Period Date
Next Filing
(est)
Price History
Loading...
Beta
-1.78
7-Day Total Return
-14.29%
30-Day Total Return
7.14%
60-Day Total Return
15.38%
90-Day Total Return
27.66%
Year to Date Total Return
27.66%
1-Year Total Return
25.00%
2-Year Total Return
-21.05%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Aug 20, 2024 - $0.13
52-week High
Mar 13, 2025 - $0.39
Valuation
Market Cap
$17.94M - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sagepotash.com
Phone Number
236 836 4182
Address
#605-899 West Pender Street
Vancouver, BC V6C 3B2
Country
Canada
Year Founded
2021
Business Description
Sector
Materials
Industry
Materials
Sage Potash Corp. engages in the acquisition, exploration, and development of mineral properties. It holds interest in the Sage Potash property located in the State of Utah. The company was... more